ABOUT MEDIPASS ABOUT MEDIPASS

ABOUT MEDIPASS

Since 1990 Medipass has partnered with public and private hospitals in Italy and abroad.
Medipass plans, implements and manages high-tech healthcare services for diagnostic imaging and can-cer diagnosis and treatment.
Medipass solutions range from overall clinical management of a single medical service to the manage-ment of complex technology parks.
Medipass helps its customers implement their projects, thus allowing them to focus on their core activi-ty: patient treatment.
The Medipass quality system is certified by CERMET and complies with the ISO 9001:2008 norm.

Medipass, a leader in the provision of high-tech services, operates in two main medical areas, imaging and cancer care, with three different management models.

NUMBERS

Total

250.000

Number services provided (overall)

Daily

400

Number services provided

Uptime

98,80%

HISTORY

OUR HISTORY, OUR MISSION: HIGH-TECH DIAGNOSTIC AND THERAPEUTIC SERVICES IN CONSTANT EVOLUTION.

In 1990 Medipass began providing MRI services, then expanded to support hospitals in the process of technological innovation, particularly in the sectors of Nuclear Medicine and Radiotherapy for cancer treatment. In 2006 it became part of the KOS group (www.kosgroup.com), strengthening its position and becoming an established partner of public and private healthcare providers in high-tech diagnostic and treatment services.

In 2016 Medipass manages a broad spectrum of hospital technology parks and radiology, nuclear medicine and radiotherapy departments, with over 9,400 machines in use, of which 170 are high-tech devices including linear accelerators (LINAC), PET-CT and Spect-CT scanners, radiopharmacy units with cyclotrons, angiography units and hybrid operating rooms. Medipass manages 37 hospital departments, supervising each from the planning stage, to the installation of equipment, to the integration of the hospital in the clinical management of the facility.

With 400 employees and contractors, it operates in Italy, the UK and India.

Medipass Healthcare Ltd (www.medipasshealthcare.com), was founded in London in 2011. It manages the technology within two of the most important NHS Cancer Health Care Centres in the UK: Belfast City Hospital (10 linacs) and the St. James Institute of Oncology in Leeds (12 linacs).

ClearMedi (www.clearmedi.com), founded in New Delhi in 2011, already operates more than 15 Radiotherapy, Nuclear Medicine and Diagnostic Imaging departments in private hospitals across India.

In the last year, Medipass helped delivery over 700,000 diagnostic and therapeutic procedures.

MILESTONES

MILESTONES
QUALITY SYSTEM

QUALITY SYSTEM

The Medipass quality system complies with the ISO 9001:2008 norm and is certi-fied by CERMET. This guarantees that service standards remain constant and uni-form.
The processes of optimisation of the Quality Management System guarantees, through constant monitoring, corrective action and a process of continuous im-provement, that the Company is able to meet customer requirements efficiently.

CODE OF CONDUCT

Medipass recognises the importance of corporate social responsibilities, and pursues its objectives while establishing and maintaining a relationship of mutual trust between stakeholders, contractors and the relevant community, in full respect of the law and of the principles of honesty, impartiality and transparency. Employees and all those involved in Medipass are required to abide by the rules and regulations established in the company’s Code of Conduct.